Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
January 09 2004 - 4:06PM
PR Newswire (US)
Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
SAN DIEGO, Jan. 9 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. will be presenting at the JPMorgan Healthcare Conference on
Monday, January 12, 2004 at 10:00 a.m. Pacific Time in San
Francisco, California. Ginger L. Graham, President and Chief
Executive Officer of Amylin Pharmaceuticals, will be providing a
corporate overview and an update on recent company activities. The
company will also participate in a breakout session immediately
following the presentation at 10:30 a.m. Pacific Time. The live
presentation and breakout session will be webcast separately, and
recordings will be made available following the events. The
webcasts and the recordings will be accessible through Amylin's
corporate website, located at http://www.amylin.com/ . To access
the live webcasts, please log on to Amylin's site approximately
fifteen minutes prior to the presentation to register and download
any necessary audio software. Amylin Pharmaceuticals is committed
to improving the lives of people with diabetes and other metabolic
diseases through the discovery, development and commercialization
of innovative, cost-effective medicines. DATASOURCE: Amylin
Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of
Finance and Chief Financial Officer of Amylin Pharmaceuticals,
Inc., +1-858-552-2200 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024